Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Hamborner REIT AG has revised its portfolio composition to materially reduce office weighting and provided guidance for the 2026 financial year, forecasting funds from operations (FFO) between €38.0 million and €42.0 million and expected rental income of €87.5 million to €89.5 million. The firm attributes a projected decline in rental receipts to p…
Atomera Incorporated (NASDAQ:ATOM) saw its stock fall 15% on Monday after announcing a $25 million registered direct offering to institutional investors. The company agreed to sell 5,000,000 shares at $5.00 per share under a securities purchase agreement, with the transaction expected to close on or about February 24, 2026, subject to customary clo…
Gilead Sciences agreed to acquire Arcellx for $115 in cash per share plus a $5 contingent value right, an agreement that values Arcellx at about $7.8 billion. The transaction, approved by both boards and expected to close in Q2 2026 subject to customary conditions, consolidates Gilead's control of anito-cel, an investigational BCMA-directed CAR T t…
Citi told clients that fourth-quarter results and steady consensus estimates underpin its optimistic outlook for 2026. Analyst Scott Chronert reiterated that the firm "maintains a constructive fundamental outlook for 2026," citing positive Q4 2025 earnings trends, accelerating sales across market caps and an above-consensus S&P 500 earnings project…
Alphabet is investing heavily in AI infrastructure and that shows up in higher capex talk. Don’t confuse temporary spend with impaired economics: the company still generates $73.3B of free cash flow, trades at ~29x earnings, and Google Cloud growth is re-accelerating. This trade targets a rebound toward the 52-week highs as AI monetization and ente…
A joint assessment by the World Bank, United Nations, European Commission and the Ukrainian government estimates Ukraine will need $588 billion to rebuild over the next ten years. The figure, covering damage and reconstruction needs from Feb. 24, 2022 through Dec. 31, 2025, marks a 12% increase from last year, driven in part by a 21% rise in harm t…
Shares of Shutterstock and Getty Images rose after the U.S. Department of Justice concluded its antitrust review and the Hart-Scott-Rodino waiting period expired without conditions, marking a key regulatory milestone for the proposed merger of equals. The companies say the deal should unlock synergies, but a Phase 2 review by the U.K. Competition a…
Federal Reserve Governor Christopher Waller said he would consider holding interest rates steady at the Fed's March meeting if February's employment report shows continued strength following an unexpectedly robust January jobs print. Waller emphasized that his March policy decision is contingent on the February payrolls reading and reiterated that …
Ukraine's Commander-in-Chief Oleksandr Syrskyi said government forces have secured 400 square kilometres, including eight settlements, along a southern front since late January. The announcement highlights localized Ukrainian advances in the Dnipropetrovsk region as debates continue over peace talks and assessments of battlefield momentum.
Two real estate investment trusts, Innovative Industrial Properties (IIPR) and Arbor Realty Trust (ABR), are attracting attention for their current yields north of 16% and multi-year payout characteristics heading into 2026. WarrenAI highlights IIPR for its consistent dividend growth and a nine-year payment streak, while ABR is noted for its high c…
UBS reduced its recommendation on Swiss regional bank Valiant Holding AG from buy to neutral while nudging its 12-month price target up to CHF168 from CHF155. The brokerage argued that the stock's rally and announced capital returns have largely captured the upside potential, leaving limited expected outperformance versus UBS's market return assump…
I argue Alphabet (GOOGL) is a tactical buy over the next 45 trading days. The SpaceX IPO and high-profile long-duration bond issuance are likely to shift investor allocations and long-term rates in ways that favor growth-with-quality names. Alphabet’s core advantages - pervasive distribution, cloud and AI infrastructure, and entrenched ad marketpla…
Warner Bros. Discovery shares gained on Monday after reports indicated that Paramount Skydance, led by David Ellison, is poised to submit an enhanced takeover proposal of $32 per share. The company faces a deadline to file a best and final offer within a weeklong window granted by Warner Bros. Discovery's board, a period that ends at 11:59 p.m. ET …
Hemisphere Energy (HMENF) is an OTC energy name trading near $1.62 with steady technical momentum, limited days-to-cover short interest, and recent volume spikes that suggest institutional size moves are unlikely to blow the stock around. For retirees or conservative allocators who want a modest allocation to small-cap energy, this is a structured …
CenterPoint Energy shares fell 2.7% to $41.85 in premarket trading after the company announced a private placement of $550 million in convertible bonds due May 2029. The Houston-based utility said net proceeds will be used for general corporate purposes, including repaying commercial paper and other debt. The move follows a record high close of $43…
UBS trimmed its price target on Sweetgreen Inc. and held a Neutral stance, pointing to continued same-store sales weakness driven by macroeconomic pressures. The bank flagged concentration in younger consumers and challenged urban markets, forecast weaker sales into 2026, and highlighted modest adjusted EBITDA expectations compared with consensus. …
ING says the US dollar has lost a portion of its safe-haven appeal since 2024, while overall demand for the currency has not broadly deteriorated. The dollar index fell almost 10% last year in its weakest annual showing since 2017. ING highlights cyclical drivers of recent weakness, continued holdings by private investors, and no current signs of a…
Director Raymond Debbane purchased 150,000 shares of Lexicon Pharmaceuticals (NASDAQ: LXRX) in two transactions on February 19-20, 2026. The buying occurred as the stock has risen 107% over the past year and follows a financing package of roughly $100 million. The FDA has cleared Lexicon's pilavapadin to advance to two Phase 3, placebo-controlled, …
Gilead Sciences agreed to acquire Arcellx for up to $7.8 billion in cash, paying $115 per share - a 79% premium to Arcellx's last close - to strengthen its cancer-treatment offerings. The deal links Gilead, through its Kite Pharma unit, to the development of anito-cel, an investigational CAR-T therapy for multiple myeloma that is under FDA review w…
Wolfe Research increased its price target for Alliant Energy to $78 from $76 and kept an Outperform rating after the utility reported results broadly in line with expectations and reaffirmed 2026 guidance. Management also maintained a 2027-2029 EPS compound annual growth rate above 7%, and the company is pursuing additional load that could add 2 to…
Deutsche Bank raised price targets across several Spanish banks and upgraded ratings for Bankinter, Banco Sabadell and CaixaBank after analysts observed stronger-than-expected net interest income resilience in 2025, diversified fee income and tighter cost control. The bank expects net interest income to resume growth in 2026 and projects returns on…
Celsius Holdings shares climbed after management disclosed larger-than-expected shelf space increases for both Alani Nu and the Celsius brand at a recent investor conference. TD Cowen reiterated a Buy rating and highlighted the quantified distribution gains, while projecting above-consensus sales and EBITDA for coming years.
Evercore ISI says the recent, indiscriminate selloff of AI-exposed stocks has opened chances to pick firms with resilient strategies. The firm argues that companies investing early in orchestration, secure enterprise guardrails and agentic execution across siloed data will be best placed as AI adoption broadens, and it names eight stocks it views a…
Goldman Sachs reiterated its Buy rating and $600.00 price target on Microsoft following the company’s announcement of the Maia 200 AI inference accelerator. The firm highlighted progress in Microsoft’s internal silicon effort and noted that early Maia disclosures point to compute performance more comparable with competitors. Analysts see significan…
Raymond James reiterated a Strong Buy rating for Palvella Therapeutics (PVLA) with a $193 price target, joining other analysts who maintain a Strong Buy consensus. Palvella raised its internal efficacy threshold for a decisive outcome in its Phase 3 MLM program to a mean mLM-IGA of at least +1.0, with an upside case of at least +1.5. The stock has …
